Sheffield Resources Limited (ASX:SFX)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	63	138	186	166	123	39
Market Cap Growth	-74.04%	-26.21%	12.11%	35.42%	218.10%	-58.83%
Enterprise Value	55	114	181	161	111	30
Last Close Price	0.16	0.35	0.47	0.48	0.35	0.13
PE Ratio	-	-	-	6.38	4.39	-
PS Ratio	-160.73	-	-	-	571.39	197.04
PB Ratio	0.56	1.00	1.10	1.07	0.96	0.45
P/TBV Ratio	0.56	1.00	1.10	1.07	0.96	0.45
EV/Sales Ratio	-	-	-	-	518.23	151.82
Debt / Equity Ratio	-	-	-	-	-	0.02
Asset Turnover	-	-	-	-	0.00	0.00
Quick Ratio	27.18	22.15	80.93	231.24	17.35	2.64
Current Ratio	27.18	22.22	81.03	231.41	17.48	2.71
Return on Equity (ROE)	-36.52%	-20.92%	-5.29%	18.37%	26.03%	-10.50%
Return on Assets (ROA)	-1.98%	-1.72%	-1.48%	-1.48%	-4.39%	-6.18%
Return on Capital (ROIC)	-1.98%	-1.72%	-1.48%	-1.49%	-4.48%	-6.47%
Earnings Yield	-79.64%	-23.39%	-4.62%	15.68%	22.80%	-21.67%
FCF Yield	-7.68%	-3.32%	-2.02%	-1.40%	-10.42%	-29.02%
Buyback Yield / Dilution	-2.87%	-8.98%	-2.92%	-0.52%	-17.06%	-21.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.